SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Jan 29 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FNS who wrote (89)4/22/1997 9:07:00 PM
From: Thean   of 965
 
Before today's analyst opinions are forgotten when next quarter comes around..., here is what happened today:

1) UBS Securites downgraded CNTO from strong buy to buy.
They cut 1997 earning to $0.52 from $0.58.
Reopro projected revenues were downgraded as follows
1997 from 259MM to 245MM
1998 from 490MM to 354MM
1999 from 649MM to 458MM

2) Cowen and Co. also downgraded from strong buy to buy. No number available.

3) Openheimer agrees with UBS's 1997's estimate of $0.52 and see $1.25 for 1998. They maintain rating at market performer.

--------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News